Tomoegawa Past Earnings Performance
Past criteria checks 2/6
Tomoegawa has been growing earnings at an average annual rate of 54.9%, while the Chemicals industry saw earnings growing at 6% annually. Revenues have been growing at an average rate of 1.7% per year. Tomoegawa's return on equity is 4.9%, and it has net margins of 1.8%.
Key information
54.9%
Earnings growth rate
54.8%
EPS growth rate
| Chemicals Industry Growth | 6.6% |
| Revenue growth rate | 1.7% |
| Return on equity | 4.9% |
| Net Margin | 1.8% |
| Last Earnings Update | 31 Mar 2024 |
Revenue & Expenses Breakdown
How Tomoegawa makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 33,692 | 594 | 4,552 | 1,377 |
| 31 Dec 23 | 33,245 | 181 | 4,936 | 931 |
| 30 Sep 23 | 33,135 | 577 | 4,796 | 931 |
| 30 Jun 23 | 33,591 | 604 | 4,624 | 931 |
| 31 Mar 23 | 34,170 | 1,401 | 4,442 | 931 |
| 31 Dec 22 | 34,396 | 1,866 | 4,624 | 582 |
| 30 Sep 22 | 34,664 | 2,076 | 4,399 | 582 |
| 30 Jun 22 | 34,141 | 2,360 | 4,237 | 582 |
| 31 Mar 22 | 32,785 | 1,650 | 4,090 | 582 |
| 31 Dec 21 | 33,129 | 1,784 | 3,826 | 771 |
| 30 Sep 21 | 32,471 | 1,351 | 3,772 | 771 |
| 30 Jun 21 | 31,255 | -91 | 3,899 | 771 |
| 31 Mar 21 | 30,768 | -1,152 | 4,112 | 771 |
| 31 Dec 20 | 29,631 | -705 | 3,903 | 950 |
| 30 Sep 20 | 29,385 | -981 | 4,077 | 950 |
| 30 Jun 20 | 30,388 | -38 | 4,176 | 950 |
| 31 Mar 20 | 30,995 | 510 | 4,155 | 950 |
| 31 Dec 19 | 31,745 | -2,179 | 4,181 | 1,043 |
| 30 Sep 19 | 32,552 | -2,300 | 4,259 | 1,043 |
| 30 Jun 19 | 32,851 | -2,228 | 4,258 | 1,043 |
| 31 Mar 19 | 33,439 | -2,032 | 4,280 | 1,043 |
| 31 Dec 18 | 32,764 | -392 | 4,271 | 1,089 |
| 30 Sep 18 | 33,177 | 55 | 4,234 | 1,089 |
| 30 Jun 18 | 33,417 | 326 | 4,181 | 1,089 |
| 31 Mar 18 | 34,374 | 418 | 4,236 | 1,089 |
| 31 Dec 17 | 35,383 | 1,229 | 4,316 | 950 |
| 30 Sep 17 | 34,835 | 1,071 | 4,205 | 950 |
| 30 Jun 17 | 34,185 | 728 | 4,133 | 950 |
| 31 Mar 17 | 32,379 | 252 | 3,931 | 950 |
| 31 Dec 16 | 32,014 | -870 | 3,685 | 1,174 |
| 30 Sep 16 | 31,725 | -1,296 | 3,631 | 1,174 |
| 30 Jun 16 | 32,503 | -1,239 | 3,671 | 1,174 |
| 31 Mar 16 | 33,502 | -929 | 3,712 | 1,174 |
| 31 Dec 15 | 33,801 | -701 | 3,720 | 1,203 |
| 30 Sep 15 | 34,533 | -354 | 3,755 | 1,203 |
| 30 Jun 15 | 34,455 | -75 | 3,779 | 1,203 |
| 31 Mar 15 | 34,114 | 48 | 3,757 | 1,203 |
| 31 Dec 14 | 33,803 | 423 | 3,676 | 1,162 |
| 30 Sep 14 | 33,737 | 638 | 3,697 | 1,162 |
| 30 Jun 14 | 34,147 | 593 | 3,647 | 1,162 |
| 31 Mar 14 | 34,613 | 606 | 3,637 | 1,162 |
| 31 Dec 13 | 35,280 | 571 | 3,699 | 1,154 |
| 30 Sep 13 | 35,192 | 345 | 3,675 | 1,154 |
| 30 Jun 13 | 34,656 | 153 | 3,717 | 1,154 |
Quality Earnings: 3878 has high quality earnings.
Growing Profit Margin: 3878's current net profit margins (1.8%) are lower than last year (4.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 3878 has become profitable over the past 5 years, growing earnings by 54.9% per year.
Accelerating Growth: 3878's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 3878 had negative earnings growth (-57.6%) over the past year, making it difficult to compare to the Chemicals industry average (8.8%).
Return on Equity
High ROE: 3878's Return on Equity (4.9%) is considered low.